Bank of New York Mellon
FBLG icon

Bank of New York Mellon’s FibroBiologics FBLG Stock Holding History

Bank of New York Mellon’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,571
Closed -$46.3K – 4286
2025
Q1 		$46.3K Buy
2,571
+51
+2% +$1.46K ﹤0.01% 4056
2024
Q4 		$101K Hold
2,520
– – ﹤0.01% 4033
2024
Q3 		$156K Sell
2,520
-908
-26% -$60.3K ﹤0.01% 3955
2024
Q2 		$342K Buy
+3,428
New +$654K ﹤0.01% 3758

Other funds holding FBLG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon's FBLG Position: Q2 2025 in Review

Bank of New York Mellon sold out of FibroBiologics (FBLG) in Q2 2025, closing a stake of 2,571 shares — an estimated $46.3K sold.

Bank of New York Mellon first reported a position in FBLG in Q2 2024 and held it in 4 quarters. The position peaked at $342K in Q2 2024. 57 funds tracked by Wall St. Rank hold FBLG as of Q2 2025.

  • Bank of New York Mellon reported no remaining FibroBiologics position as of Q2 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 2,571 FibroBiologics shares in Q2 2025, an estimated $46.3K.
  • Bank of New York Mellon first reported a position in FibroBiologics in Q2 2024 and held it in 4 quarters.
  • Bank of New York Mellon's FibroBiologics position peaked at $342K in Q2 2024.
  • 57 funds tracked by Wall St. Rank held FibroBiologics as of Q2 2025.

Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.